close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TRxADE HEALTH, Inc. - Common Stock (NQ:MEDS)

7.590 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about TRxADE HEALTH, Inc. - Common Stock

< Previous 1 2 3 4 Next >
TinyGemsBreaks – TRxAde Health Inc. (NASDAQ: MEDS) Changes Name to Scienture Holdings Inc.
Via Investor Brand Network
BioMedNewsBreaks — TRxADE Health Inc.’s (NASDAQ: MEDS) Subsidiary Expands Capabilities with Changes to Executive Leadership Team
Via Investor Brand Network
BioMedNewsBreaks — TRxAde Health Inc. (NASDAQ: MEDS), Scienture Inc. Announce All-Stock Business Combination Resulting in Combined Company
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Special Cash Dividend
Via Investor Brand Network
TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
Via ACCESSWIRE
TRxADE HEALTH Reports 16% Revenue Growth and Year End 2022 Financial Results
Via ACCESSWIRE
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Regains Compliance with Nasdaq Listing Rule 5250(c)(1), Posts Over $21M in Net Income for Q1 2024
Via Investor Brand Network
Market Momentum: Analyzing Five Stocks Exhibiting Strong Upward Trends: INBS, MEDS, IFBD, AISP, VTAK
Via AB Newswire
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Board Declares Special Cash Dividend
Via Investor Brand Network
TRxADE HEALTH Inc. (NASDAQ: MEDS) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Filing of Key Quarterly Report to Regain NASDAQ Exchange Compliance
Via Investor Brand Network
TRxADE Health (NASDAQ:MEDS), Newly Merged With Superlatus, Is Gearing Up To Make Big Splashes In the $151 Billion Snacks Industry with its Acquisition of The Urgent Company Inc.
Via ACCESSWIRE
TRxADE Health Inc. (NASDAQ: MEDS) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc.’s (NASDAQ: MEDS) Merger Partner Unveils Innovative Product It’s Bringing to Multibillion US Snacking Market
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Inks Acquisition Agreement with Perfect Day for Its Urgent Company, Consumer Brands Portfolio
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Files Extension for Form 10-Q Filing
Via Investor Brand Network
TRxADE HEALTH, INC. to Report Q2 2023 Financial Results on Monday, August 14th at 6:00 p.m. Eastern Time
Via ACCESSWIRE
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Amended, Restates Superlatus Merger Agreement
Via Investor Brand Network
InvestorNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Inks MIPA in $10M NASDAQ Merger
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS), Superlatus Inc. to Merge and Create a Global Food Consolidation Platform
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Commences Trading After Board-Approved Reverse Stock Split
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q1 Financial Results
Via Investor Brand Network
TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 15th at 6:00 p.m. Eastern Time
Via ACCESSWIRE
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Scheduled Release of Q1 2023 Financial Results, Conference Call
Via Investor Brand Network
TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 8th at 5:00 p.m. Eastern Time
Via ACCESSWIRE
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q4, Year-End 2022 Financial and Corporate Report
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Date for Release of Q4, Year-End 2022 Financial Report
Via Investor Brand Network
TRxADE HEALTH, INC. to Report Q4 and Year-End 2022 Financial Results on Monday, March 27th at 5:30 p.m. Eastern Time
Via ACCESSWIRE
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Subsidiary Signs New Telemedicine Services Agreement
Via Investor Brand Network
Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today